Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Adma Biologics (NQ: ADMA ) 19.37 +3.06 (+18.76%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Adma Biologics < Previous 1 2 3 4 5 6 7 Next > Buckle Up And Use Volitility To Your Advantage November 03, 2024 The Advance/Decline trend on the NYSE weakened; the Nasdaq A/D line is outright scary. Via Talk Markets What You Missed On Wall Street This Past Friday November 03, 2024 Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. Via Talk Markets Amazon Posts Upbeat Results, Joins Cardinal Health, Waters, Atlassian, Charter Communications, MasTec And Other Big Stocks Moving Higher On Friday November 01, 2024 Via Benzinga (ADMA) - Analyzing ADMA Biologics's Short Interest October 22, 2024 Via Benzinga Key Takeaways From ADMA Biologics Analyst Ratings October 14, 2024 Via Benzinga This Is What Whales Are Betting On ADMA Biologics October 10, 2024 Via Benzinga IBD 50's Top Stock, ADMA Biologics, Crashes After Auditor Unexpectedly Resigns October 10, 2024 The company reiterated its outlook for 2024 and 2025. Via Investor's Business Daily ADMA Biologics, A Top 1% Stock, Skyrockets After Settling Its Accounting Debacle November 01, 2024 The company signed on a new accounting firm less than a month after its previous accountant resigned unexpectedly. Via Investor's Business Daily ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024 October 29, 2024 Conference Call Scheduled for November 7, 2024, at 4:30 p.m. ET From ADMA Biologics, Inc. Via GlobeNewswire ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into ADMA Biologics Inc and Encourages Investors to Contact the Firm October 29, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Exploring high growth characteristics of ADMA BIOLOGICS INC (NASDAQ:ADMA). October 08, 2024 Why ADMA BIOLOGICS INC (NASDAQ:ADMA) qualifies as a high growth stock. Via Chartmill Looking for growth without the hefty price tag? Consider NASDAQ:ADMA. September 24, 2024 Looking for growth without the hefty price tag? Consider NASDAQ:ADMA. Via Chartmill In-Depth Examination Of 4 Analyst Recommendations For ADMA Biologics September 20, 2024 Via Benzinga ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into ADMA Biologics Inc and Encourages Investors to Contact the Firm October 28, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Bragar Eagel & Squire, P.C. Is Investigating ADMA Biologics, Napco, and L&W and Encourages Investors to Contact the Firm October 21, 2024 From Bragar Eagel & Squire Via GlobeNewswire ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is Investigating ADMA Biologics, Inc. on Behalf of ADMA Biologics Stockholders and Encourages Investors to Contact the Firm October 15, 2024 From Bragar Eagel & Squire Via GlobeNewswire Amphastar Casts Wide Net, Hauls In Profits, Gets Rating Upgrade October 15, 2024 Amphastar hit an all-time high in August 2023 and consolidated. It could be forming the right side of a cup base that started in January. Via Investor's Business Daily Alkermes Stock Jumps Nearly 30% In 3 Months Amid Hefty Profits October 14, 2024 Alkermes develops treatments for neurodegenerative diseases (conditions that damage and destroy parts of the nervous system) and cancer. Via Investor's Business Daily CVS Has 'Real Value,' Jim Cramer Says: Micron Had An 'Amazing' Quarter October 11, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session October 10, 2024 Via Benzinga ADMA Biologics Set to Join S&P SmallCap 600 Index September 17, 2024 From ADMA Biologics, Inc. Via GlobeNewswire ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference September 10, 2024 From ADMA Biologics, Inc. Via GlobeNewswire What's Going On With ADMA Biologics Stock Monday? September 09, 2024 ADMA Biologics shares are moving higher after it was announced that the company will join the S&P SmallCap 600. Via Benzinga Topics Stocks Exposures US Equities Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday September 09, 2024 Via Benzinga Keros Therapeutics Stock Meets 80-Plus RS Rating Benchmark September 05, 2024 Building your watch list, look for stocks with an 80-plus RS Rating. Keros Therapeutics stock just met that criteria with a new score of 86. Via Investor's Business Daily 'This Is A Very Speculative Situation,' Jim Cramer On ADMA Biologics August 30, 2024 "Mad Money" host Jim Cramer said, "Any time there's immunity-compromised patients, there's some big money down the road." Via Benzinga Innovative Drugmaker Roivant Puts Up Really Healthy Sales Numbers August 29, 2024 Roivant stock has an outstanding A- Accumulation/Distribution Rating, showing that institutions such as mutual funds are fairly heavy buyers. Via Investor's Business Daily Biohaven Stock Earns Relative Strength Rating Upgrade August 21, 2024 Biohaven stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, rising from 88 to 91. Via Investor's Business Daily SpringWorks Therapeutics Stock Clears Key Benchmark, Hitting 80-Plus RS Rating August 21, 2024 A Relative Strength Rating upgrade for SpringWorks Therapeutics shows improving technical performance. Via Investor's Business Daily Immunome Stock Sees RS Rating Jump To 91 August 20, 2024 Immunome stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 88 to 91. Via Investor's Business Daily < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
